Latest Brookfield Asset Management Inc (BAM) Headl
Post# of 37
Posted On: 03/14/2014 11:39:22 AM
Latest Brookfield Asset Management Inc (BAM) Headlines
IIROC Trade Resumption - BAM.PR.J
CNW Group - Thu Mar 06, 9:18AM CST
Trading resumes in:
IIROC Trading Halt - BAM.PR.J
CNW Group - Thu Mar 06, 9:12AM CST
The following issues have been halted by IIROC:
IIROC Trade Resumption - Brookfield Asset Management Inc.
Newsfile Corp - Thu Mar 06, 9:06AM CST
Trading resumes in:
IIROC Trade Halt - Brookfield Asset Management Inc.
Newsfile Corp - Thu Mar 06, 8:58AM CST
The following issues have been halted by IIROC:
Brookfield's Ric Clark Elected Board Chair of the National Eating Disorders Association
Business Wire - Thu Feb 27, 5:00AM CST
During the National Eating Disorder Association's 27th annual Awareness Week (Feb. 23 - March 1), it is especially exciting to announce the election of Ric Clark as the Chair of its Board of Directors.
Anti-Racists Take France to Court Over Colonial-Era Congo Forced Labour
by Sarah Elzas - All Africa Global Media - Wed Feb 26, 5:58AM CST
A coalition of black rights groups is suing the French state and a construction company for crimes against humanity over the use of forced labour to build a railway line in Congo in the 1920s.
Research and Markets: Japan Hip Reconstruction Market Outlook to 2020
Business Wire - Wed Feb 26, 4:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/hvbctw/japan_hip) has announced the addition of the "Japan Hip Reconstruction Market Outlook to 2020" report to their offering.
Fitch Affirms Brookfield Asset Management's IDR at 'BBB'; Outlook Stable
Business Wire - Tue Feb 25, 3:30PM CST
Fitch Ratings has affirmed the Issuer Default Rating (IDR) and senior unsecured debt rating of Brookfield Asset Management Inc. (BAM) at 'BBB'. The Rating Outlook is Stable. Approximately CAD$4.5 billion of long-term debt is affected by this rating action.
Brookfield Asset Management Reports Consolidated Net Income of $3.8 Billion and Funds from Operations of $3.4 Billion
Marketwire - Fri Feb 14, 6:56AM CST
Brookfield Asset Management Inc. (NYSE: BAM)(TSX: BAM.A)(EURONEXT: BAMA) -
Global Chemicals for Water-intensive Industries Market 2014-2018: Demand from APAC Region Expected to be Higher than other Regions
M2 - Thu Feb 13, 5:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/ljjllr/global_chemicals) has announced the addition of the "Global Chemicals for Water-intensive Industries Market 2014-2018" report to their offering. The analysts forecast the Global Chemicals for Water-intensive Industries market to grow at a CAGR of 3.28 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand from the Oil and Mining industry. The Global Chemicals for Water-intensive Industries market has also been witnessing the provision of supporting services by vendors. However, volatile raw material costs could pose a challenge to the growth of this market. Key vendors dominating this space are AkzoNobel N.V., Ashland Inc., BASF SE, and Kemira Oyj. Other vendors mentioned in the report are Accepta, AMC Oil and Gas, AMCOL International Corp., Aquatech International Corp., Aries Chemical Inc., Ashahi Chemical Industries Ltd., Cubane Specialty Chemicals Pvt. Ltd., Chemical Products Corp., Cheminova AS, Chevron Phillips Chemical Co., Clariant International AG, Cytec Industries Inc., Dow Chemical Co., Dow Corning Corp., Evonik Industries AG, FMC Corp., Georgia-Pacific Chemicals LLC, Gulf Chemicals and Industrial Oils Co., Hunstman International LLC, Hydrite Chemical Co., Imperial Oilfield Chemicals Pvt. Ltd., K-Tech India Ltd., Lenntech B.V, Nalco Holding Co., Nuplex Industries Ltd., Orica Ltd., Outotech Oyj, Pristine Water Solutions Inc., Raj Chemicals Ltd., REDA Oilfield, Royal Dutch Shell plc, Sasol Ltd., Sivira Organiks Pvt. Ltd., Solvay SA, Taminco Corp., and Troy Paper Chemicals Commenting on the report, an analyst from the team said: The Global Chemicals for Water-intensive Industries market is expected to witness increasing demand from the APAC region. Demand from the APAC region is expected to be higher than that of other regions due to the strong growth of various industries such as Pulp and Paper. Also, with thriving economies such as India and China posting high gross domestic product growth rates, the demand from various industries such as Waste water Treatment is also expected to increase substantially during the forecast period. Moreover, several vendors are expected to set up production facilities in this region to cater to the growing demand. For more information visit http://www.researchandmarkets.com/research/lj..._chemicals About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NBS Payment Solutions Acquires The Assets of Equinox Payments
Marketwire - Thu Feb 06, 5:55PM CST
NBS Payment Solutions Inc. ("NBSPS") announced today that it has completed the acquisition of substantially all of the assets of Equinox Payments, LLC ("Equinox"). Equinox is a leading provider of payment terminals, applications and support services in the United States. NBSPS is a leading provider of payment terminals, applications and services to the Canadian market and is a wholly-owned subsidiary of Brookfield Asset Management Inc. Terms of the transaction were not disclosed.
Construction in Venezuela to 2017: Market Forecast Report
M2 - Thu Feb 06, 2:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/43p5m5/construction_in) has announced the addition of the "Construction in Venezuela to 2017: Market Forecast" report to their offering. 'Construction in Venezuela to 2017: Market Forecast' contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. This report is the result of extensive market research covering the construction industry in Venezuela. It contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Construction in Venezuela to 2017: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the construction industry in Venezuela. It is an essential tool for companies active across the Venezuelan construction value chain and for new players considering to enter the market. Scope - Overview of the construction industry in Venezuela. - Historic and forecast market value for the construction industry by construction output and value-add methods for the period 2008 through to 2017. - Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the construction industry for the period 2008 through to 2017. Key Topics Covered: Introduction Construction: Industry Analysis Construction: Activity Breakdown Commercial Construction: Category Analysis Industrial Construction: Category Analysis Infrastructure Construction: Category Analysis Institutional Construction: Category Analysis Residential Construction: Category Analysis Appendix List of Tables List of Figures For more information visit http://www.researchandmarkets.com/research/43...ruction_in About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Bronchiolitis Obliterans - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/pd2t7t/bronchiolitis) has announced the addition of the "Bronchiolitis Obliterans - Pipeline Review, H2 2013" report to their offering. 'Bronchiolitis Obliterans - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans. Scope - A snapshot of the global therapeutic scenario for Bronchiolitis Obliterans. - A review of the Bronchiolitis Obliterans products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Bronchiolitis Obliterans pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Bronchiolitis Obliterans Overview Therapeutics Development Pipeline Products for Bronchiolitis Obliterans - Overview Pipeline Products for Bronchiolitis Obliterans - Comparative Analysis Bronchiolitis Obliterans - Therapeutics under Development by Companies Bronchiolitis Obliterans - Therapeutics under Investigation by Universities/Institutes Bronchiolitis Obliterans - Pipeline Products Glance Late Stage Products Clinical Stage Products Bronchiolitis Obliterans - Products under Development by Companies Bronchiolitis Obliterans - Products under Investigation by Universities/Institutes Bronchiolitis Obliterans - Companies Involved in Therapeutics Development Bronchiolitis Obliterans - Therapeutics Assessment Drug Profiles cyclosporine - Drug Profile cyclosporine liposomal - Drug Profile bortezomib - Drug Profile interferon gamma-1b - Drug Profile (pentoxifylline N-acetylcysteine) - Drug Profile Bronchiolitis Obliterans - Recent Pipeline Updates Bronchiolitis Obliterans - Dormant Projects Bronchiolitis Obliterans - Product Development Milestones Featured News & Press Releases Companies Mentioned PARI Pharma GmbH Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/pd...nchiolitis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Helios High Yield Fund Announces Results of Special Shareholder Meeting
Marketwire - Fri Jan 31, 3:21PM CST
Helios High Yield Fund (NYSE: HHY) (the "Fund") today announced that, at its special shareholder meeting, shareholders of the Fund approved the redomestication of the Fund into a Maryland corporation and amendments to the Fund's governing documents. Additionally, shareholders approved a new investment advisory agreement between the Fund and Brookfield Investment Management. The redomestication is expected to be consummated on or about February 28, 2014.
Ex-Dividend Alert: 5 Stocks Going Ex-Dividend Tomorrow: FTF, TGP, BAM, EPD, MS
at The Street - Tue Jan 28, 9:00AM CST
FTF TGP BAM EPD MS are going ex-dividend tomorrow, Wednesday, Jan. 29, 2014, 5:00 AM ET
Fitch Rates Brookfield Asset Management's Debt Securities 'BBB'; Outlook Stable
Business Wire - Fri Jan 24, 10:54AM CST
Fitch Ratings has assigned a 'BBB' rating to Brookfield Asset Management Inc.'s (BAM) C$500 million, 4.82% 12-year medium-term notes due Jan. 28, 2026. The Rating Outlook is Stable.
Brookfield Asset Management 2013 Q4 Results Conference Call and Webcast Notice for Investors and Analysts
Marketwire - Wed Jan 15, 11:14AM CST
Brookfield Asset Management Inc. (TSX: BAM.A)(NYSE: BAM)(EURONEXT: BAMA) -
IIROC Trade Resumption - BAM.PR.J
CNW Group - Thu Mar 06, 9:18AM CST
Trading resumes in:
IIROC Trading Halt - BAM.PR.J
CNW Group - Thu Mar 06, 9:12AM CST
The following issues have been halted by IIROC:
IIROC Trade Resumption - Brookfield Asset Management Inc.
Newsfile Corp - Thu Mar 06, 9:06AM CST
Trading resumes in:
IIROC Trade Halt - Brookfield Asset Management Inc.
Newsfile Corp - Thu Mar 06, 8:58AM CST
The following issues have been halted by IIROC:
Brookfield's Ric Clark Elected Board Chair of the National Eating Disorders Association
Business Wire - Thu Feb 27, 5:00AM CST
During the National Eating Disorder Association's 27th annual Awareness Week (Feb. 23 - March 1), it is especially exciting to announce the election of Ric Clark as the Chair of its Board of Directors.
Anti-Racists Take France to Court Over Colonial-Era Congo Forced Labour
by Sarah Elzas - All Africa Global Media - Wed Feb 26, 5:58AM CST
A coalition of black rights groups is suing the French state and a construction company for crimes against humanity over the use of forced labour to build a railway line in Congo in the 1920s.
Research and Markets: Japan Hip Reconstruction Market Outlook to 2020
Business Wire - Wed Feb 26, 4:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/hvbctw/japan_hip) has announced the addition of the "Japan Hip Reconstruction Market Outlook to 2020" report to their offering.
Fitch Affirms Brookfield Asset Management's IDR at 'BBB'; Outlook Stable
Business Wire - Tue Feb 25, 3:30PM CST
Fitch Ratings has affirmed the Issuer Default Rating (IDR) and senior unsecured debt rating of Brookfield Asset Management Inc. (BAM) at 'BBB'. The Rating Outlook is Stable. Approximately CAD$4.5 billion of long-term debt is affected by this rating action.
Brookfield Asset Management Reports Consolidated Net Income of $3.8 Billion and Funds from Operations of $3.4 Billion
Marketwire - Fri Feb 14, 6:56AM CST
Brookfield Asset Management Inc. (NYSE: BAM)(TSX: BAM.A)(EURONEXT: BAMA) -
Global Chemicals for Water-intensive Industries Market 2014-2018: Demand from APAC Region Expected to be Higher than other Regions
M2 - Thu Feb 13, 5:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/ljjllr/global_chemicals) has announced the addition of the "Global Chemicals for Water-intensive Industries Market 2014-2018" report to their offering. The analysts forecast the Global Chemicals for Water-intensive Industries market to grow at a CAGR of 3.28 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand from the Oil and Mining industry. The Global Chemicals for Water-intensive Industries market has also been witnessing the provision of supporting services by vendors. However, volatile raw material costs could pose a challenge to the growth of this market. Key vendors dominating this space are AkzoNobel N.V., Ashland Inc., BASF SE, and Kemira Oyj. Other vendors mentioned in the report are Accepta, AMC Oil and Gas, AMCOL International Corp., Aquatech International Corp., Aries Chemical Inc., Ashahi Chemical Industries Ltd., Cubane Specialty Chemicals Pvt. Ltd., Chemical Products Corp., Cheminova AS, Chevron Phillips Chemical Co., Clariant International AG, Cytec Industries Inc., Dow Chemical Co., Dow Corning Corp., Evonik Industries AG, FMC Corp., Georgia-Pacific Chemicals LLC, Gulf Chemicals and Industrial Oils Co., Hunstman International LLC, Hydrite Chemical Co., Imperial Oilfield Chemicals Pvt. Ltd., K-Tech India Ltd., Lenntech B.V, Nalco Holding Co., Nuplex Industries Ltd., Orica Ltd., Outotech Oyj, Pristine Water Solutions Inc., Raj Chemicals Ltd., REDA Oilfield, Royal Dutch Shell plc, Sasol Ltd., Sivira Organiks Pvt. Ltd., Solvay SA, Taminco Corp., and Troy Paper Chemicals Commenting on the report, an analyst from the team said: The Global Chemicals for Water-intensive Industries market is expected to witness increasing demand from the APAC region. Demand from the APAC region is expected to be higher than that of other regions due to the strong growth of various industries such as Pulp and Paper. Also, with thriving economies such as India and China posting high gross domestic product growth rates, the demand from various industries such as Waste water Treatment is also expected to increase substantially during the forecast period. Moreover, several vendors are expected to set up production facilities in this region to cater to the growing demand. For more information visit http://www.researchandmarkets.com/research/lj..._chemicals About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NBS Payment Solutions Acquires The Assets of Equinox Payments
Marketwire - Thu Feb 06, 5:55PM CST
NBS Payment Solutions Inc. ("NBSPS") announced today that it has completed the acquisition of substantially all of the assets of Equinox Payments, LLC ("Equinox"). Equinox is a leading provider of payment terminals, applications and support services in the United States. NBSPS is a leading provider of payment terminals, applications and services to the Canadian market and is a wholly-owned subsidiary of Brookfield Asset Management Inc. Terms of the transaction were not disclosed.
Construction in Venezuela to 2017: Market Forecast Report
M2 - Thu Feb 06, 2:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/43p5m5/construction_in) has announced the addition of the "Construction in Venezuela to 2017: Market Forecast" report to their offering. 'Construction in Venezuela to 2017: Market Forecast' contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. This report is the result of extensive market research covering the construction industry in Venezuela. It contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Construction in Venezuela to 2017: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the construction industry in Venezuela. It is an essential tool for companies active across the Venezuelan construction value chain and for new players considering to enter the market. Scope - Overview of the construction industry in Venezuela. - Historic and forecast market value for the construction industry by construction output and value-add methods for the period 2008 through to 2017. - Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the construction industry for the period 2008 through to 2017. Key Topics Covered: Introduction Construction: Industry Analysis Construction: Activity Breakdown Commercial Construction: Category Analysis Industrial Construction: Category Analysis Infrastructure Construction: Category Analysis Institutional Construction: Category Analysis Residential Construction: Category Analysis Appendix List of Tables List of Figures For more information visit http://www.researchandmarkets.com/research/43...ruction_in About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Bronchiolitis Obliterans - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/pd2t7t/bronchiolitis) has announced the addition of the "Bronchiolitis Obliterans - Pipeline Review, H2 2013" report to their offering. 'Bronchiolitis Obliterans - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans. Scope - A snapshot of the global therapeutic scenario for Bronchiolitis Obliterans. - A review of the Bronchiolitis Obliterans products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Bronchiolitis Obliterans pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Bronchiolitis Obliterans Overview Therapeutics Development Pipeline Products for Bronchiolitis Obliterans - Overview Pipeline Products for Bronchiolitis Obliterans - Comparative Analysis Bronchiolitis Obliterans - Therapeutics under Development by Companies Bronchiolitis Obliterans - Therapeutics under Investigation by Universities/Institutes Bronchiolitis Obliterans - Pipeline Products Glance Late Stage Products Clinical Stage Products Bronchiolitis Obliterans - Products under Development by Companies Bronchiolitis Obliterans - Products under Investigation by Universities/Institutes Bronchiolitis Obliterans - Companies Involved in Therapeutics Development Bronchiolitis Obliterans - Therapeutics Assessment Drug Profiles cyclosporine - Drug Profile cyclosporine liposomal - Drug Profile bortezomib - Drug Profile interferon gamma-1b - Drug Profile (pentoxifylline N-acetylcysteine) - Drug Profile Bronchiolitis Obliterans - Recent Pipeline Updates Bronchiolitis Obliterans - Dormant Projects Bronchiolitis Obliterans - Product Development Milestones Featured News & Press Releases Companies Mentioned PARI Pharma GmbH Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/pd...nchiolitis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Helios High Yield Fund Announces Results of Special Shareholder Meeting
Marketwire - Fri Jan 31, 3:21PM CST
Helios High Yield Fund (NYSE: HHY) (the "Fund") today announced that, at its special shareholder meeting, shareholders of the Fund approved the redomestication of the Fund into a Maryland corporation and amendments to the Fund's governing documents. Additionally, shareholders approved a new investment advisory agreement between the Fund and Brookfield Investment Management. The redomestication is expected to be consummated on or about February 28, 2014.
Ex-Dividend Alert: 5 Stocks Going Ex-Dividend Tomorrow: FTF, TGP, BAM, EPD, MS
at The Street - Tue Jan 28, 9:00AM CST
FTF TGP BAM EPD MS are going ex-dividend tomorrow, Wednesday, Jan. 29, 2014, 5:00 AM ET
Fitch Rates Brookfield Asset Management's Debt Securities 'BBB'; Outlook Stable
Business Wire - Fri Jan 24, 10:54AM CST
Fitch Ratings has assigned a 'BBB' rating to Brookfield Asset Management Inc.'s (BAM) C$500 million, 4.82% 12-year medium-term notes due Jan. 28, 2026. The Rating Outlook is Stable.
Brookfield Asset Management 2013 Q4 Results Conference Call and Webcast Notice for Investors and Analysts
Marketwire - Wed Jan 15, 11:14AM CST
Brookfield Asset Management Inc. (TSX: BAM.A)(NYSE: BAM)(EURONEXT: BAMA) -
(0)
(0)Brookfield Corporation (BN) Stock Research Links
Scroll down for more posts ▼